189 Episodo

  1. Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Publicado: 7/5/2024
  2. Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer

    Publicado: 28/3/2024
  3. Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer

    Publicado: 18/3/2024
  4. Current Considerations for Adverse Event Management With HER3-Directed Agents

    Publicado: 26/12/2023
  5. Unpacking the Potential of HER3-Targeted Therapy in NSCLC

    Publicado: 26/12/2023
  6. Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer

    Publicado: 26/12/2023
  7. Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

    Publicado: 4/12/2023
  8. Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis

    Publicado: 30/11/2023
  9. A Year in Review and a Look to the Future: BTKi in CLL and MCL

    Publicado: 20/11/2023
  10. Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

    Publicado: 17/11/2023
  11. Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer

    Publicado: 7/11/2023
  12. Improving Care for Black Patients With Endometrial Cancer

    Publicado: 6/11/2023
  13. Expert Insight on Key Updates and New Clinical Trial Data From the ESGO 2023 Congress Informing Treatment for Cervical, Ovarian, and Endometrial Cancers

    Publicado: 13/10/2023
  14. New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023

    Publicado: 4/10/2023
  15. New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023

    Publicado: 17/8/2023
  16. New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023

    Publicado: 28/7/2023
  17. Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers

    Publicado: 22/6/2023
  18. Expert Insight on New Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

    Publicado: 4/5/2023
  19. Practical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma

    Publicado: 26/4/2023
  20. Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts

    Publicado: 11/4/2023

2 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site